Waters Corporation witnessed a significant uptick in its stock price yesterday, climbing 3.3% to close at $328.73. This notable advance was primarily fueled by Rothschild Redburn, which commenced coverage of the company with a highly optimistic “Buy” recommendation. The financial services firm set a price target of $390 for the shares, indicating substantial potential upside from current levels.
Strong Fundamentals Underpin Positive Outlook
The company’s robust financial health provides a solid foundation for this bullish sentiment. For the second quarter of 2025, Waters reported revenue of $771 million, exceeding market expectations and delivering an 8% increase in earnings. The firm’s gross margin stood at an impressive 59.02%, highlighting its operational efficiency and pricing power within the sector.
Rothschild Redburn’s analysis emphasized Waters’ position as the premier pure-play provider in analytical instruments, noting its industry-leading EBITA margins of 31%. A key strength identified was the company’s recurring revenue model, with approximately 60% of sales originating from services and consumables dedicated to the pharmaceutical industry.
Strategic Acquisition Reshapes Market Position
A transformative development for Waters is its planned acquisition of Becton Dickinson’s biosciences and diagnostics division, valued at $17.5 billion. Market experts view this transaction as a potential game-changer that will effectively double the company’s addressable market to an estimated $40 billion. This expanded market is projected to grow at an annual rate of 5-7%, providing significant long-term growth opportunities.
Should investors sell immediately? Or is it worth buying Waters?
The acquisition process is expected to conclude in early 2026, positioning the combined entity as a dominant force in the life sciences sector. According to Rothschild Redburn’s projections, the merged company could achieve annual EPS growth of 14% through 2029.
Divergent Views Create Market Uncertainty
While Rothschild Redburn expresses strong conviction, the broader analyst community presents a more varied perspective. Weiss Ratings simultaneously reaffirmed its “Hold” rating on Waters shares. Other financial institutions, including Stifel and KeyBanc, maintain positions ranging from “Hold” to “Overweight,” reflecting differing assessments of how the acquisition will impact the company’s future performance.
Market participants are looking toward November 4th for greater clarity, when Waters is scheduled to release its quarterly earnings. This upcoming report could determine whether the stock maintains its upward trajectory or faces a corrective phase, making the current trading environment particularly significant for investors monitoring this evolving situation.
Ad
Waters Stock: Buy or Sell?! New Waters Analysis from October 9 delivers the answer:
The latest Waters figures speak for themselves: Urgent action needed for Waters investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 9.
Waters: Buy or sell? Read more here...